|
1
|
Bhat AH, Dar KB, Anees S, Zargar MA,
Masood A, Sofi MA and Ganie SA: Oxidative stress, mitochondrial
dysfunction and neurodegenerative diseases; a mechanistic insight.
Biomed Pharmacother. 74:101–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thanan R, Oikawa S, Hiraku Y, Ohnishi S,
Ma N, Pinlaor S, Yongvanit P, Kawanishi S and Murata M: Oxidative
stress and its significant roles in neurodegenerative diseases and
cancer. Int J Mol Sci. 16:193–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bonilha VL, Rayborn ME, Yang X, Xie C and
Cai H: Oxidative stress regulation by DJ-1 in the retinal pigment
epithelium. Adv Exp Med Biol. 801:649–654. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu Y, Tang L and Chen B: Oxidative stress:
Implications for the development of diabetic retinopathy and
antioxidant therapeutic perspectives. Oxid Med Cell Longev.
2014:7523872014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pinazo-Durán MD, Gallego-Pinazo R,
García-Medina JJ, Zanón-Moreno V, Nucci C, Dolz-Marco R,
Martínez-Castillo S, Galbis-Estrada C, Marco-Ramírez C,
López-Gálvez MI, et al: Oxidative stress and its downstream
signaling in aging eyes. Clin Interv Aging. 9:637–652. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Campochiaro PA, Strauss RW, Lu L, Hafiz G,
Wolfson Y, Shah SM, Sophie R, Mir TA and Scholl HP: Is there excess
oxidative stress and damage in eyes of patients with retinitis
pigmentosa? Antioxid Redox Signal. 23:643–648. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao K, Zhao GM, Wu D, Soong Y, Birk AV,
Schiller PW and Szeto HH: Cell-permeable peptide antioxidants
targeted to inner mitochondrial membrane inhibit mitochondrial
swelling, oxidative cell death, and reperfusion injury. J Biol
Chem. 279:34682–34690. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao K, Luo G, Zhao GM, Schiller PW and
Szeto HH: Transcellular transport of a highly polar 3+ net charge
opioid tetrapeptide. J Pharmacol Exp Ther. 304:425–432. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao K, Luo G, Giannelli S and Szeto HH:
Mitochondria-targeted peptide prevents mitochondrial depolarization
and apoptosis induced by tert-butyl hydroperoxide in neuronal cell
lines. Biochem Pharmacol. 70:1796–1806. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Szeto HH: Mitochondria-targeted peptide
antioxidants: Novel neuroprotective agents. AAPS J. 8:E521–E531.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iizuka Y, Hong S, Kim CY, Kim SK and Seong
GJ: Agmatine pretreatment protects retinal ganglion cells (RGC-5
cell line) from oxidative stress in vitro. Biocell. 32:245–250.
2008.PubMed/NCBI
|
|
12
|
Shimazawa M, Nakajima Y, Mashima Y and
Hara H: Docosahexaenoic acid (DHA) has neuroprotective effects
against oxidative stress in retinal ganglion cells. Brain Res.
1251:269–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen M, Liu B, Gao Q, Zhuo Y and Ge J:
Mitochondria-targeted peptide MTP-131 alleviates mitochondrial
dysfunction and oxidative damage in human trabecular meshwork
cells. Invest Ophthalmol Vis Sci. 52:7027–7037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koriyama Y, Ohno M, Kimura T and Kato S:
Neuroprotective effects of 5-S-GAD against oxidative stress-induced
apoptosis in RGC-5 cells. Brain Res. 1296:187–195. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou X, Su CF, Zhang Z, Wang CY, Luo JQ,
Zhou XW, Cai L, Yan L, Zhang W and Luo HM: Neuroprotective effects
of methyl 3,4-dihydroxybenzoate against H2O2-induced apoptosis in
RGC-5 cells. J Pharmacol Sci. 125:51–58. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jia WC, Liu G, Zhang CD and Zhang SP:
Formononetin attenuates hydrogen peroxide (H2O2)-induced apoptosis
and NF-κB activation in RGC-5 cells. Eur Rev Med Pharmacol Sci.
18:2191–2197. 2014.PubMed/NCBI
|
|
17
|
Wang R, Peng L, Zhao J, Zhang L, Guo C,
Zheng W and Chen H: Gardenamide A protects RGC-5 cells from
H2O2-induced oxidative stress insults by activating PI3K/Akt/eNOS
signaling pathway. Int J Mol Sci. 16:22350–22367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang P, Huang C, Wang W and Wang M: Early
changes in staurosporine-induced differentiated RGC-5 cells
indicate cellular injury response to nonlethal blue light exposure.
Photochem Photobiol Sci. 14:1093–1099. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding W, Shang L, Huang JF, Li N, Chen D,
Xue LX and Xiong K: Receptor interacting protein 3-induced RGC-5
cell necroptosis following oxygen glucose deprivation. BMC
Neurosci. 16:492015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sippl C and Tamm ER: What is the nature of
the RGC-5 cell line? Adv Exp Med Biol. 801:145–154. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Al-Ubaidi MR: RGC-5: Are they really 661W?
The saga continues. Exp Eye Res. 119:1152014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mao H, Seo SJ, Biswal MR, Li H, Conners M,
Nandyala A, Jones K, Le YZ and Lewin AS: Mitochondrial oxidative
stress in the retinal pigment epithelium leads to localized retinal
degeneration. Invest Ophthalmol Vis Sci. 55:4613–4627. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Birk AV, Chao WM, Bracken C, Warren JD and
Szeto HH: Targeting mitochondrial cardiolipin and the cytochrome
c/cardiolipin complex to promote electron transport and optimize
mitochondrial ATP synthesis. Br J Pharmacol. 171:2017–2028. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szeto HH: First-in-class
cardiolipin-protective compound as a therapeutic agent to restore
mitochondrial bioenergetics. Br J Pharmacol. 171:2029–2050. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu J, Zhang M, Hao S, Jia M, Ji M, Qiu L,
Sun X, Yang J and Li K: Mitochondria-targeted peptide reverses
mitochondrial dysfunction and cognitive deficits in
sepsis-associated encephalopathy. Mol Neurobiol. 52:783–791. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ajith TA and Jayakumar TG:
Mitochondria-targeted agents: Future perspectives of mitochondrial
pharmaceutics in cardiovascular diseases. World J Cardiol.
6:1091–1099. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Birk AV, Liu S, Soong Y, Mills W, Singh P,
Warren JD, Seshan SV, Pardee JD and Szeto HH: The
mitochondrial-targeted compound SS-31 re-energizes ischemic
mitochondria by interacting with cardiolipin. J Am Soc Nephrol.
24:1250–1261. 2013. View Article : Google Scholar : PubMed/NCBI
|
